Archives: News
- 
            NewsResearch paper highlighted at the Movement Disorders Society CongressLearn moreA paper published by the Molecular and Functional Neurobiology group at the LCSB was mentioned during the Movement Disorders Society meeting organised in Madrid in September 2022. The study, focusing on the role of different cell types present in the human midbrain in Parkinson’s disease, was highlighted during the plenary session in a list of interesting fundamental research published this… 
- 
            NewsMultiple Types of Long COVID Identified for the First TimeLearn moreAll-Luxembourg study finds that Long COVID is not just a single disease but can take a variety of forms with different symptoms and potential treatments. 
- 
            NewsThe Expobiome Map – Exploring the role of microbiome-derived moleculesLearn moreThe human microbiome, the collection of microorganisms that live in and on our body, is intricately connected to our health. Recent studies have shown that these microbial communities are implicated in various diseases and that the molecules they produce could be drivers of many pathogenic processes including inflammation. However, much remains to be discovered about… 
- 
            News19 PhD positions in immunology and chronic inflammation – Apply now!Learn moreIn the framework of the NextImmune2 Doctoral Training Unit, the University of Luxembourg and the Luxembourg Institute of Health (LIH) are recruiting 19 PhD students to work on research projects focusing on next generation immunoscience. 
- 
            NewsSurprising Connection between Immune Balance, Ageing and Parkinson’sLearn moreLuxembourg Institute of Health (LIH) experts together with collaborators from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg have begun to unravel the complex links between a key Parkinson’s disease protein and the functionality of specialised immune cells (T cells) with regulatory suppressive functions during ageing. The findings may provide a… 
- 
            NewsInternational team discovers endogenous anti-inflammatory substanceLearn moreA research team led by Prof. Karsten Hiller of the Braunschweig Integrated Centre of Systems Biology, BRICS, in collaboration with scientists at the Luxembourg Institute of Health (LIH) and the University of Luxembourg has discovered an anti-inflammatory chemical substance that the body naturally produces: mesaconic acid. This molecule could be a candidate for further development… 
- 
            NewsMidbrain single-cell sequencing to understand Parkinson’s DiseaseLearn moreResearchers from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg, in collaboration with the Max Planck Institute for Molecular Genetics in Berlin, investigated the different cell types present in the human midbrain to better understand their respective role in Parkinson’s disease. They examined post-mortem samples from people affected by the disease and… 
- 
            NewsPaul Wilmes elected Executive Board member of the Section des SciencesLearn moreOn 9 February, Prof. Paul Wilmes, head of the Systems Ecology group at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, was elected as a member of the executive board of the Section des Sciences of the Institut Grand-Ducal. 
- 
            NewsThe Luxembourg Centre for Systems Biomedicine opens its doors!Learn moreIf you ever wondered what biomedical research is and what a laboratory looks like, then join us for a guided tour in our wet and dry labs! 
- 
            News88,000 euros awarded for the 9th edition of Espoir en têteLearn moreThe Rotary Clubs of Luxembourg were able to collect important donations from private donors and their sponsors, despite the cancellation of the traditional screening of a special film in the Kinepolis cinemas.